Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
– Agreement expansion facilitates preparation for commercial readiness for CABA-201, enabling treatment of patients in…
– Agreement expansion facilitates preparation for commercial readiness for CABA-201, enabling treatment of patients in…
– Agreement expansion facilitates preparation for commercial readiness for CABA-201, enabling treatment of patients in…
60P was awarded additional U.S. patent protection to further solidify its exclusive rights through 2035…
60P was awarded additional U.S. patent protection to further solidify its exclusive rights through 2035…
Phase 1 trial expected to begin in early Q4 2023 VIP943 is Vincerx’ first candidate…
Phase 1 trial expected to begin in early Q4 2023 VIP943 is Vincerx’ first candidate…
BEDMINSTER, N.J., Aug. 22, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage…
BEDMINSTER, N.J., Aug. 22, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage…
WINNIPEG, Manitoba, Aug. 22, 2023 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
WINNIPEG, Manitoba, Aug. 22, 2023 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
Presentations Highlight New Data on Diagnostic Accuracy and Novel Biomarkers of Disease Severity in Multiple…
Presentations Highlight New Data on Diagnostic Accuracy and Novel Biomarkers of Disease Severity in Multiple…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR…
CAMBRIDGE, Mass., Aug. 22, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage…
CAMBRIDGE, Mass., Aug. 22, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage…
Significant progress with lead program LAVA-1207 in mCRPC reaching dose level 8 Significant progress with…
Significant progress with lead program LAVA-1207 in mCRPC reaching dose level 8 Significant progress with…
Julia Macharey Photograph of Julia Macharey standing up and looking into the camera. ORION CORPORATION…
Julia Macharey Photograph of Julia Macharey standing up and looking into the camera. ORION CORPORATION…